What is the current share price of Amrutanjan Health Care Limited (AMRUTANJAN)?

As of the latest market update, Amrutanjan Health Care Limited (AMRUTANJAN) is trading at ₹557.7. The stock has moved 0.82% down in the recent session.

What is the technical sentiment for AMRUTANJAN stock?

Based on our proprietary technical analysis, the current signal for AMRUTANJAN is "SELL". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Amrutanjan Health Care Limited?

Amrutanjan Health Care Limited has seen a 52-week high of ₹790.95 and a 52-week low of ₹486. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Amrutanjan Health Care Limited belong to?

Amrutanjan Health Care Limited operates in the Healthcare sector, specifically within the Pharmaceuticals & Biotechnology industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of AMRUTANJAN?

Amrutanjan Health Care Limited (AMRUTANJAN) has a market capitalization of approximately ₹1.61K Cr. This classifies it as a small cap stock in the Indian market.

AMRUTANJAN

NSE

Amrutanjan Health Care Limited (SMALL CAP)

Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals

₹557.70

4.60 (0.82%)

High VOLATILITY

As on 12 Jun 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹1.61K Cr

SMALL CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

28.1

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Pharmaceuticals

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹486+14.8%

52W High₹790.95-29.5%

Current Price

₹557.70

Circuit Limits (20%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹446.16

Upper Circuit₹669.24

Reference Price

₹557.70

Investment Checklist

Head and Shoulders on 1W (BREAKOUT CONFIRMED) — target ₹515.05

Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹583.75

Volume divergence: Bullish (price down, volume up)

EMA(9) Crossover: Price crossed below EMA(9): Fresh bearish weakness signal.

SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))

Technical Analysis

Analysis from 2026-06-12

Confidence

49%

Trend

NEUTRAL

Mixed MA signals — sideways/transition

EMA20

557.64

EMA50

557.13

EMA200

615.61

Price Action

MIXED

NEUTRAL

Higher Highs4

Higher Lows4

Lower Highs5

Lower Lows5

Support & Resistance Levels

Resistance (Above)

₹563.50

₹572.40

₹588.00

₹598.00

₹628.80

Support (Below)

₹541.20

₹530.30

₹498.00

₹486.00

Volume Analysis

TrendINCREASING

Change+33.00%

Unusual VolumeNo

Divergence Detected

Bullish (price down, volume up)

Stop Loss Levels

Fixed Risk

1% Risk₹552.12

3% Risk₹540.97

5% Risk₹529.82

7% Risk (Custom)

₹518.66

Technical Levels

1x ATR (Volatility)₹540.69

2x ATR (Swing)₹523.68

3x ATR (Trend)₹506.67

Immediate Support₹541.20

Moving Averages

EMA 20 (Medium-term)₹557.64

EMA 50 (Trend)₹557.13

Financials

Financial Analysis

Metric	Mar '25	Jun '25	Sep '25	Dec '25
Revenue	₹134.1 Cr	₹94 Cr	₹117.7 Cr	₹141 Cr
Net Profit	₹15.2 Cr	₹8.3 Cr	₹14 Cr	₹19.5 Cr
EPS	—	₹2.87	₹4.83	₹6.73
Operating Profit	₹22.5 Cr	₹12.9 Cr	₹20.8 Cr	₹28 Cr

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol	Name	Price	Change
SUNPHARMA	Sun Pharmaceutical Industries Limited	₹1,807.70	+0.75%
DIVISLAB	Divi's Laboratories Limited	₹6,638.00	-0.26%
TORNTPHARM	Torrent Pharmaceuticals Limited	₹4,571.20	-0.02%
CIPLA	Cipla Limited	₹1,389.40	+0.44%
ZYDUSLIFE	Zydus Lifesciences Limited	₹1,104.70	-0.11%
DRREDDY	Dr. Reddy's Laboratories Limited	₹1,275.40	-0.05%
LUPIN	Lupin Limited	₹2,293.30	+0.88%
MANKIND	Mankind Pharma Limited	₹2,381.10	+0.35%
AUROPHARMA	Aurobindo Pharma Limited	₹1,472.80	+0.59%
LAURUSLABS	Laurus Labs Limited	₹1,394.30	+0.25%

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All

Ex Date	Purpose	Type
06 Feb 2026	Interim Dividend - Re 1 Per Share	INTERIM_DIVIDEND
18 Nov 2025	Interim Dividend - Re 1 Per Share	INTERIM_DIVIDEND
16 Sept 2025	Dividend - Rs 2.60 Per Share	DIVIDEND
18 Feb 2025	Interim Dividend - Re 1 Per Share	INTERIM_DIVIDEND
22 Nov 2024	Interim Dividend - Re 1 Per Share	INTERIM_DIVIDEND

Announcements

Latest updates

View All

Date	Description	Link
27 May 2026	Updates
27 May 2026	Change in Director(s)
19 May 2026	Shareholders meeting
18 May 2026	Shareholders meeting
13 May 2026	Updates

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
08 May 2026	Financial Results/Dividend
08 May 2026	Board Meeting Intimation	XBRL
03 Feb 2026	Board Meeting Intimation	XBRL
03 Feb 2026	Financial Results/Dividend
10 Nov 2025	Board Meeting Intimation	XBRL

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for AMRUTANJAN

View All

Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 crore

positive

ET Markets - Industry 4d ago

Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 crore

Viyash Scientific, backed by Carlyle, is acquiring Italy's BioForLife for Rs. 188 crore. This move aims to build a leading global companion animal health business. BioForLife offers a strong presence in the Italian pet care market. The acquisition is expected to finalize in the second quarter of FY 2026-27.

AGARWALEYEAMRUTANJANGLOBALGLOBALPETMEDANTAPGHHVIYASHZOTACapital GoodsConsumer Services

Read full story

NEWS

positive

Business Standard - Markets 5d ago

Viyash Scientific to acquire Milan-based pet care company BioForLife

Viyash Scientific (Viyash), through its wholly owned subsidiary Alivira Animal Health (Alivira), has signed a binding agreement to acquire 100% stake in BioForLife Italia S.r.l. (BFL), a leading pet care company based in Milan, Italy. The acquisition, for a cash consideration of Rs 188 crore is expected to close in Q2 FY27.

AGARWALEYEAMRUTANJANGLOBALPETMEDANTAPGHHVIYASHZOTACapital GoodsFast Moving Consumer Goods

Read full story

NEWS

positive

Business Standard - Markets 5d ago

Viyash Scientific rises after subsidiary inks Rs 188-crore deal to acquire Italy's BioForLife

Viyash Scientific rose 1.59% to Rs 259.20 after the company's wholly owned subsidiary, Alivira Animal Health, has inked a binding agreement to acquire a 100% stake in BioForLife Italia S.r.l. (BFL), a leading pet care company based in Milan, Italy.

AGARWALEYEAMRUTANJANGLOBALPETMEDANTAPGHHVIYASHZOTACapital GoodsFast Moving Consumer Goods

Read full story

AMRUTANJAN

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Stop Loss Levels

Fixed Risk

Technical Levels

Moving Averages

Financials

Financial Analysis

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Corporate Actions

Announcements

Board Meetings

Corporate Events

Shareholding Pattern

Shareholding Pattern

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for AMRUTANJAN

Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 crore

Viyash Scientific to acquire Milan-based pet care company BioForLife

Viyash Scientific rises after subsidiary inks Rs 188-crore deal to acquire Italy's BioForLife

Frequently Asked Questions

What is the current share price of Amrutanjan Health Care Limited (AMRUTANJAN)?

What is the technical sentiment for AMRUTANJAN stock?

What is the 52-week high and low for Amrutanjan Health Care Limited?

Which sector does Amrutanjan Health Care Limited belong to?

What is the market capitalization of AMRUTANJAN?